{"organizations": [], "uuid": "e558cb63506cdfcbf4747dfd4115548b92bf9dcf", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.stockhouse.com", "main_image": "", "site_section": "http://www.stockhouse.com/discovery/technology", "section_title": "The Technology Report - Technology investor news and research center ", "url": "http://www.stockhouse.com/news/micro-cap-report/2015/09/28/microcap-report-aeterna-t-aez-gains-steam-imperus-v-lab-fumbles", "country": "US", "title": "MicroCap Report: AEterna (T.AEZ) gains steam, Imperus (V.LAB) fumbles-T.AEZ-V.LAB-", "performance_score": 0, "site": "stockhouse.com", "participants_count": 1, "title_full": "MicroCap Report: AEterna (T.AEZ) gains steam, Imperus (V.LAB) fumbles-T.AEZ-V.LAB-Stockhouse news", "spam_score": 0.0, "site_type": "news", "published": "2015-09-28T03:00:00.000+03:00", "replies_count": 0, "uuid": "e558cb63506cdfcbf4747dfd4115548b92bf9dcf"}, "author": "Stockhouse Editorial", "url": "http://www.stockhouse.com/news/micro-cap-report/2015/09/28/microcap-report-aeterna-t-aez-gains-steam-imperus-v-lab-fumbles", "ord_in_thread": 0, "title": "MicroCap Report: AEterna (T.AEZ) gains steam, Imperus (V.LAB) fumbles-T.AEZ-V.LAB-", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "AEterna Zentaris ( TSX: AEZ , Forum ) climbed a little on the boards today after the company released news regarding the clinical trials of its Zoptarelin Doxorubicin, a drug geared for the treatment of castration and taxane Resistant Prostate Cancer.\nAccording to the news release , the drug, formally known as AEZS-108, had met the primary end point of the investigator-driven and sponsored Phase 2 clinical trial and demonstrated good tolerability. Shares were up 16.67% to $0.14 per share.\nImperus Technologies ( TSX: V.LAB , Forum ) took a wash on SP today when the company announced that it had amended an option agreement related to a proposed acquisition of a social gaming company earlier this morning.\nAccording to the news release , the deadline for the option to acquire Akamon, was pushed six weeks from September 25, 2015 to November 9, 2015. This delay had some investors hopping mad as they felt management was fumbling the ball on an important merger. This dismay translated to a high volume sell, driving down the stock. Shares dropped 28.57% to $0.125 per share.\nSelect Canadian Small/Micro-cap Advancers (as of 4:00 PM Eastern) AEterna Zentaris Inc. ( T.AEZ , Stock Forum ) 16.67% Horizons BetaPro S&P\\/TSX Global Gold Bear Plus ETF ( T.HGD , Stock Forum ) 8.90% Horizons BetaPro NASDAQ-100 Bear Plus ETF ( T.HQD , Stock Forum ) 5.78% Horizons BetaPro S&P\\/TSX 60 Bear Plus ETF ( T.HXD , Stock Forum ) 5.41% Horizons BetaPro S&P 500 Bear Plus ETF ( T.HSD , Stock Forum ) 5.02% Select Canadian Small/Micro-cap Decliners (as of 4:00 PM Eastern) Imperus Technologies Corp. ( V.LAB , Stock Forum ) -28.57% Trevali Mining Corporation ( T.TV , Stock Forum ) -24.10% NexGen Energy Ltd. ( V.NXE , Stock Forum ) -16.42% GuestLogix Inc. ( T.GXI , Stock Forum ) -14.93% Sphere 3D Corp ( ANY , Stock Forum ) -14.22%\nTags: TECHNOLOGY HEALTHCARE BIOTECHNOLOGY SOFTWARE - APPLICATION", "external_links": [], "published": "2015-09-28T03:00:00.000+03:00", "crawled": "2015-09-30T06:07:03.409+03:00", "highlightTitle": ""}